These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 19621145)

  • 1. [An update on antifungal susceptibility testing].
    Tapia P CV
    Rev Chilena Infectol; 2009 Apr; 26(2):144-50. PubMed ID: 19621145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in antifungal susceptibility testing using CLSI reference and commercial methods.
    Cantón E; Espinel-Ingroff A; Pemán J
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):107-19. PubMed ID: 19622060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility-testing in Aspergillus species.
    Lass-Flörl C; Perkhofer S
    Mycoses; 2008 Sep; 51(5):437-46. PubMed ID: 18422914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro.
    Cuenca-Estrella M; Rodriguez-Tudela JL
    Expert Rev Anti Infect Ther; 2010 Mar; 8(3):267-76. PubMed ID: 20192681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
    Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast One.
    Carrillo-Muñoz AJ; Quindós G; Ruesga M; del Valle O; Pemán J; Cantón E; Hernández-Molina JM; Santos P
    Mycoses; 2006 Jul; 49(4):293-7. PubMed ID: 16784443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro methods for antifungal susceptibility testing of Trichophyton spp.
    Barros ME; Santos Dde A; Hamdan JS
    Mycol Res; 2006 Nov; 110(Pt 11):1355-60. PubMed ID: 17070026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Sensititre YeastOne colorimetric antifungal panel with the modified Clinical and Laboratory Standards Institute broth microdilution (M38-A) method for antifungal susceptibility testing of dermatophytes.
    Castro C; Serrano MC; Valverde A; Pemán J; Almeida C; Martín-Mazuelos E
    Chemotherapy; 2008; 54(6):427-30. PubMed ID: 18824849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
    Cuenca-Estrella M; Gomez-Lopez A; Gutierrez MO; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1062-5. PubMed ID: 18195057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal susceptibility testing: progress and future developments.
    Pfaller MA
    Braz J Infect Dis; 2000 Apr; 4(2):55-60. PubMed ID: 11012296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between CLSI, EUCAST and Etest methodologies for amphotericin B and fluconazole antifungal susceptibility testing of Candida spp. clinical isolates.
    Claudino AL; Peixoto RF; Melhem MS; Szeszs MW; Lyon JP; Chavasco JK; Franco MC
    Pharmazie; 2008 Apr; 63(4):286-9. PubMed ID: 18468388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques.
    Cuenca-Estrella M; Gomez-Lopez A; Mellado E; Rodriguez-Tudela JL
    Clin Microbiol Infect; 2005 Jun; 11(6):486-92. PubMed ID: 15882199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the results of in vitro antifungal susceptibility testing using the Fungitest kit and the disc diffusion test].
    Buchta V; Navrátilová L; Förstl M; Kubanová P
    Klin Mikrobiol Infekc Lek; 2004 Apr; 10(2):80-7. PubMed ID: 15146386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
    Lee SC; Lo HJ; Fung CP; Lee N; See LC
    J Microbiol Immunol Infect; 2009 Apr; 42(2):148-53. PubMed ID: 19597647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of antifungal susceptibility testing methods.
    Arikan S
    Med Mycol; 2007 Nov; 45(7):569-87. PubMed ID: 17885947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility testing in Aspergillus species: an update.
    Lass-Flörl C
    Future Microbiol; 2010 May; 5(5):789-99. PubMed ID: 20441550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal susceptibility testing method for resource constrained laboratories.
    Khan S; Singhal S; Mathur T; Upadhyay DJ; Rattan A
    Indian J Med Microbiol; 2006 Jul; 24(3):171-6. PubMed ID: 16912435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of in vitro antifungal susceptibility testing.
    Espinel-Ingroff A
    Rev Esp Quimioter; 2000 Jun; 13(2):161-6. PubMed ID: 10918088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal susceptibility testing by flow cytometry: is it the future?
    Vale-Silva LA; Buchta V
    Mycoses; 2006 Jul; 49(4):261-73. PubMed ID: 16784439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determining the susceptibility of microfungi to antifungals and interpreting the results].
    Mallátová N
    Klin Mikrobiol Infekc Lek; 2007 Aug; 13(4):150-5. PubMed ID: 17929220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.